ESC 365 - Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

ESC Premium Access

Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

Session: Atrial fibrillation ablation: stroke and bleeding

Topic: Pathophysiology and Mechanisms

Speaker: Professor M. Glikson (Jerusalem, IL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)

21 presentations

1 follower

3 more presentations in this session

Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

Speaker: Professor L. Di Biase (The Bronx, US)

Silent brain lesions and clinically relevant bleeds - the next frontiers for making atrial fibrillation ablation safer.

Speaker: Professor L. Mont (Barcelona, ES)

The key question: can anticoagulation be abandoned after catheter ablation of atrial fibrillation?

Speaker: Doctor A. Verma (Montreal, CA)

Access the full session

Atrial fibrillation ablation: stroke and bleeding

Speakers: Professor M. Glikson, Professor L. Di Biase, Professor L. Mont, Doctor A. Verma

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources